Results 21 to 30 of about 70,433 (233)
Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy
Bagcilar Medical Bulletin, 2016 Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the ...
Lebriz Uslu Besli, Ilhami Uslu
doaj +1 more source
World Journal of Nuclear Medicine, 2016 The influence of antithyroid drugs (ATDs) on the therapeutic efficacy of radioactive iodine in hyperthyroidism is still controversial. The aim of this study was to evaluate the effect of ATD discontinuation to the therapeutic efficacy of I-131 in ...
A. Hussein Sundawa Kartamihardja +1 more
doaj +1 more source
Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease [PDF]
Arhiv za farmaciju, 2017 Radioactive iodine represents the significant therapeutic option in the treatment of benign thyroid disease. Despite a decades-long experience and a large number of treated patients, many issues related to the therapy with radioactive iodine are still ...
Topić-Vučenović Valentina +4 more
doaj +1 more source
Radiation Protection and Environment, 2020 Nonconjugated conductive polymers have unique characteristics for providing protection against nuclear radiation including radioactive iodine (carcinogenic) which remains in vapor phase at and above room temperature and is difficult to contain.
Mrinal Thakur
doaj +1 more source
Stable BF2 Boracycles as Versatile Reagents for Selective Ortho C–H Functionalization
Angewandte Chemie, EarlyView.We report a robust, metal‐free and scalable synthesis of stable BF2 boracycles via directed ortho CH borylation, delivering isolable, shelf‐stable reagents without chromatographic purification. These BF2 boracycles exhibit unique and tunable reactivity, enabling highly selective ipso‐functionalization across a broad range of transformations.
Ganesh H. Shinde +11 more
wiley +2 more sources
LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
Опухоли головы и шеи, 2017 Well-differentiated thyroid carcinoma (WDTC) comprises > 90 % of all cases of thyroid cancer. In 10–15 % of patients, distant metastases are detected which significantly worsen the prognosis.
I. S. Romanov +6 more
doaj +1 more source
ENDOCRINE TUMOURS: Imaging in the follow up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach [PDF]
, 2016 The clinical and epidemiological profiles of differentiated thyroid cancers (DTCs) have changed in the last three decades. Today's DTCs are more likely to be small, localized, asymptomatic papillary forms.
Deandreis, Désirée +3 more
core +1 more source
Nuclear Engineering and Technology, 2019 Experimental equipment for studying the sorption properties of iodine sorbents using radioactive methyliodide has been developed. The sorption capacity index α is proposed as a criterion parameter for assessing the quality of impregnated activated ...
Eldar P. Magomedbekov +1 more
doaj +1 more source
A role for the small GTPases RAC1 and RAC1b in the modulation of NIS expression: potentiation of therapy with radioactive iodine in differentiated thyroid carcinoma [PDF]
, 2019 Introduction or Background: The Sodium Iodide Symporter (NIS) is responsible for active transport of iodide into thyroid follicular cells. The retention of its functional expression in most of the well-differentiated thyroid carcinomas (DTCs) enables ...
Bugalho, Maria J. +5 more
core +1 more source
BMC Endocrine Disorders, 2021 Background The main purpose is to investigate the effect of LiCO3 as an add-on therapy with radioactive iodine in increasing the cure and decreasing the T4 level compared to radioactive iodine alone. The primary outcome is the cure rate as defined by the
Mohamed Abd-ElGawad +7 more
doaj +1 more source